J9280 Mitomycin injection
Also known as: mitomycin, Mitomycin C
Injection of mitomycin, an antibiotic-derived alkylating agent. A cross-linking chemotherapy used for multiple malignancies.
In Plain Language
cancer chemotherapy injection; alkylating agent
Clinical Context
Used for gastric, pancreatic, and breast cancers in combination regimens. Also used for bladder cancer via intravesical instillation.
RVU Information
CPT J9280 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9280?
CPT J9280 (Mitomycin injection) is a J Codes (Drugs) code. Injection of mitomycin, an antibiotic-derived alkylating agent. A cross-linking chemotherapy used for multiple malignancies.
How is J9280 administered?
CPT J9280 is administered by a healthcare provider, typically via injection or infusion. Used for gastric, pancreatic, and breast cancers in combination regimens. Also used for bladder cancer via intravesical instillation. It is used by Oncology, Surgery, Urology.
When is CPT J9280 used?
Used for gastric, pancreatic, and breast cancers in combination regimens. Also used for bladder cancer via intravesical instillation.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.